The Recall Lawyers are Reviewing Risperdal Cases Now
Risperdal, a drug approved for treatment of schizophrenia, bipolar disorder, and management of behavioral problems in kids with autism, has come under fire for off-label use as an anti-depressant.
Recently, the Attorney General of Arkansas won a $1.2 billion judgment against the makers of Risperdal. However, this judgment was recently overturned.
Nevertheless, lawsuits brought by individuals who have been harmed by Risperdal– in particular, young men and teenage boys who developed breasts– are increasing.